Work

Pembrolizumab monotherapy for high-risk, non-muscle invasive bladder cancer – Authors' reply

Year: 2021

Type: letter

Source: The Lancet Oncology

DOI: 10.1016/s1470-2045(21)00478-2

Authors: Arjun V Balar, Ashish M Kamat, Ronald de Wit

Institutions: NYU Langone Health, NYU Langone’s Laura and Isaac Perlmutter Cancer Center, The University of Texas MD Anderson Cancer Center, Erasmus MC

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3197808792

Cites: 3

Cited by: 7

Related to: 10